1. The intrarenal role of angiotensin I1 in controlling sodium excretion was examined in anaesthetized, dehydrated dogs by infusing the angiotensin I1 antagonist Sar1-Ile8-angiotensin I1 directly into the renal artery. Comparisons were made with dehydrated dogs receiving only sodium chloride solution intrarenally.
Introduction
Studies with angiotensin I1 antagonists have consistently shown an important role of endogenous angiotensin I1 in the regulation of renal blood flow during high-renin states such as sodium depletion; however, conflict persists as to the intrarenal role of angiotensin I1 in con-' trolling urinary sodium excretion. Some investigators have found no consistent change in urinary sodium excretion when the competitive antagonist Sar '-Ala'-angiotensin I1 was infused directly into the renal artery of dogs having high plasma renin activity due to experimental heart failure, vena caval constriction or sodium depletion (Freeman, Davis, Vitale & Johnson, 1973; Freeman, Davis, Spielman & Lohmeier, 1975) . Conversely, others found significant increases in urinary sodium excretion in sodium-depleted dogs after intrarenal infusion of the converting enzyme inhibitor SQ 20881 (Gagnon, Rice & Flamenbaum, 1974; Kimbrough, Vaughan, Carey & Ayers, 1975) . In sodium-depleted rabbits, neither the angiotensin I1 antagonist nor the converting enzyme inhibitor produced an increase in urinary sodium excretion when infused intravenously (Mimran, Guiod & Hollenberg, 1974) .
Possible reasons for the inconsistent effects of the blocking agents of the renin-angiotensin system on sodium excretion are: (1) the use of different types of blocking agents (unlike the competitive antagonists of angiotensin 11, converting enzyme inhibitor potentiates the action of bradykinin, which is a natriuretic agent); (2) variable falls in mean arterial pmsure during blockade of the renin-angiotensin system may cause various degrees of antinatriuresis; (3) changes in the rate of sodium excretion during the experimental period due to undefined responses of the experimental animal to prolonged anaesthesia, surgery and other altered physiological variables.
In this study we have examined the effect of intrarenal infusion of the angiotensin I1 antagonist Sarl-IleE-angiotensin I1 on urinary sodium excretion and other renal functions in dehydrated dogs, where plasma renin activity was high. The doses and antagonist used were chosen to eliminate the problems of bradykinin potentiation and arterial pressure lowering. To assess the role of anaesthesia and surgery in the experimental results, control studies were made in a group of dehydrated dogs not receiving the antagonist.
Methods
Eleven dogs of either sex, weighing 15-25 kg and maintained on standard dry dog food (12% water content) ad libitum, were dehydrated by water deprivation for 4 days. Subsequently, the dogs were anaesthetized with sodium pentobarbital (30 mg/kg). Appropriate blood vessels were catheterized for intravenous infusion and arterial pressure recording.
Through a retroperitoneal flank incision catheters were placed in the left renal vein (via the gonadal vein) and left ureter, and a noncannulating electromagnetic flow probe was placed on the left renal artery for measuring renal blood flow. Flow probes were previously calibrated with a stop watch and graduated cylinder with dog blood flowing through transected renal arteries in situ or carotid arteries in vitro. Zero flow was checked by occluding the renal artery after each experiment. A curved 23 gauge needle was inserted into the left renal artery, and an infusion of sodium chloride solution (1 54 mmol/l; saline) was begun at 0.1 1 ml/min. At 1-2 h after surgery, arterial blood was collected for analysis of plasma renin activity and electrolytes. The effects on renal function of intrarenal infusion of Sar '-Ilea-angiotensin I1 (3.66 mmol/min, 4 .ug/min) were determined in five dogs. This dose of antagonist, which was dissolved in saline and infused at 0.11 ml/min, completely abolished the renal responses to intrarenal injections of 485 pmol (500 ng) of angiotensin 11. Others have reported on the blocking potency and intrinsic activity of Sar1-Ile8-angiotensin I1 (Bravo, Khosla & Bumpus, 1975; Munoz-Ramirez, Khosla, Bumpus & Khairallah, 1975) .Variables were measured at intervals during a 40 niin control period, a 90 min period of antagonist infusion, and 60 min after stopping the antagonist infusion (recovery). Saline was infused intrarenally (0.11 ml/min) during the control and recovery periods. The same protocol was used in six control dogs except that saline was infused instead of antagonist.
Mean arterial pressure and urine flow were determined with a Statham transducer and a photoelectric drop counter and recorded on a polygraph (Grass). Renal filtration fraction (FF) was determined from the renal arteriovenous extraction of 251]iotha1amate, which was infused intravenously throughout the experiment in a solution of saline at 0.2 ml/min. Glomerular filtration rate (GFR) was calculated according to the formula:
This method for measuring glomerular filtration rate has been previously reported (Elwood & Sigman, 1967; Kishimoto, Maekawa, Miyazaki, Yamamoto & Ueda, 1972; Hall & Guyton, 1976 
Results
After 4 days of water deprivation average body weight of the 11 dogs fell from 21.1 to 19.3 kg and average plasma sodium concentration increased from 142 to 154 mmol/l; plasma renin activity averaged 8.44 ng of angiotensin I h -* ml-' (SEM 1.82, n = 7). Previous values of plasma renin activity in normally hydrated anaesthetized dogs that had been maintained on standard dry dog food and water ad libitum averaged 1.54 ng of angiotensin I h-' ml-' (SEM 0-24, n = 10). Large increases in both urine flow and urinary sodium excretion occurred after 60 and 90 min of intrarenal infusion of angiotensin I1 antagonist (Fig. 1) ; these changes were significantly greater than those observed in the salineinfused control group. The difference in urine flow changes between the two groups was also significant at 30 min, but 60 min after stopping the antagonist infusion, urine flow and sodium excretion did not differ significantly between the two groups. Mean arterial pressure did not change significantly in either group. Renal blood flow and glomerular filtration rate tended to increase in the antagonist group at 60 and 90 min, but these changes were not significantly different from those in the saline-infused control group.
However, when the results were analysed by paired analysis within each group, the increases in renal blood flow and glomerular filtration rate were significant at 90 min in the antagonist group but not in the saline-infused group. In the antagonist group, the mean difference from control (ml min-I g-I kidney weight k SEM) for renal blood flow and glomerular filtration rate were 0.65 rt0-13 (P<O.Ol) and 0.12 Jt 0.02 (P <0.01) respectively. The respective values for the salineinfused control group (ml min-1 g-I kidney weight f SEM) were 0. 15k0.16 (P>0.3) and 0.03 k0.03 (P>0.3) .
Discussion
The results show that in dogs with elevated plasma renin activity due to dehydration intrarenal angiotensin I1 blockade signscantly increases urinary sodium excretion and urine flow. This demonstrates that endogenous angiotensin I1 has intrarenal actions which lead to salt and water retention. The increase in sodium excretion found in this study probably cannot be explained by the antagonism of aldosterone secretion, since Sarl-Iles-angiotensin I1 does not effectively block the steroidogenic properties of angiotensin I1 at these doses (Bravo et al., 1975) . In fact, the dose of Sar'-Iles-angiotensin I1 used in the present study has been shown to increase, rather than decrease, plasma aldosterone concentration in normal anaesthetid dogs (Beckerhoff, Uhlschmid, Furrer, Nussberger, Schmied, Vetter & Siegenthaler, 1975) .
Freeman er al. (1975) found a statistically signilicant increase in sodium excretion in sodium-depleted dogs after intrarenal infusion of Sarl-Alas-angiotensin 11, but concluded that this response had no significance since sodium excretion never returned to the control value after cessation of the antagonist. However, since a comparison with a saline-infused control group was not made in that study, the significance of the finding is not known . Mimran et al. (1974) found no change in sodium excretion in sodium-depleted rabbits after intravenous administration of Sarl-Alas-angiotensin I1 or SQ 20881, but, as they pointed out, the marked decrease in arterial pressure observed in their experiments may have obliterated any natriuretic response.
